Biogen (BIIB): STATE STREET CORP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
State Street Corp. disclosed a stake exceeding 5% in Biogen (BIIB) via a Schedule 13G filing with the SEC (accession 0000093751-26-000623). The filing signals that the institutional investor has crossed the key 5% threshold that triggers disclosure obligations for beneficial owners. Biogen shares are now on watch for any further stake adjustments by State Street, as 13G filers must amend when holdings shift materially. The exact share count and percentage were not specified in the headline disclosure. Investors will look to the full filing for precise ownership figures and any stated intent.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Biogen (BIIB), State Street Corp
A linked name opens that asset's sentiment page.